Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients

References

• Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Planté V, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000;123:1495–1504.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113–1116.
   PubMed Web of Science ®Google Scholar
• Parrilla P, Ramirez P, Andreu LF, Bueno SF, Robles R, Miras M, Acosta F, et al. Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I. Transplantation 1997;64:646–649.
   PubMed Web of Science ®Google Scholar
• Suhr OB, Ericzon BG, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002;8:787–794.
   PubMed Web of Science ®Google Scholar
• Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, et al. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996;62:1037–1038.
   PubMed Web of Science ®Google Scholar
• Sandgren O, Kjellgren D, Suhr OB. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol 2008;86:520–524.
   PubMed Web of Science ®Google Scholar
• Hörnsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004;78:112–116.
   PubMed Web of Science ®Google Scholar
• Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74–80.
   PubMed Web of Science ®Google Scholar
• Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O’Grady J, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis. Transplantation 1998;66:229–233.
   PubMed Web of Science ®Google Scholar
• Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, Adams D, et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 2006;85:229–238.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Yamashita T, Ando Y, Ueda M, Misumi Y, Obayashi K, Horibata Y, Uchino M. Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation. Intern Med 2008;47:2133–2137.
   PubMed Web of Science ®Google Scholar
• Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73:745–751.
   PubMed Web of Science ®Google Scholar
• Yazaki M, Mitsuhashi S, Tokuda T, Kametani F, Takei YI, Koyama J, Kawamorita A, et al. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007;7:235–242.
   PubMed Web of Science ®Google Scholar
• Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994;235:479–485.
   PubMed Web of Science ®Google Scholar
• Hörnsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB. Heart complications in familial transthyretin amyloidosis: Impact of age and gender. Amyloid 2010;17:63–68.
   PubMed Web of Science ®Google Scholar
• Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 2008;216:253–261.
   PubMed Web of Science ®Google Scholar
• Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999;122 (Pt 10):1951–1962.
   PubMedGoogle Scholar
• Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881–1891.
   PubMed Web of Science ®Google Scholar
• Jacobson DR, Pastore R, Pool S, Malendowicz S, Kane I, Shivji A, Embury SH, et al. Revised transthyretin Ile 122 allele frequency in African–Americans. Hum Genet 1996;98:236–238.
   PubMed Web of Science ®Google Scholar
• Ranløv I, Alves IL, Ranløv PJ, Husby G, Costa PP, Saraiva MJ. A Danish kindred with familial amyloid cardiomyopathy revisited: Identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers. Am J Med 1992;93:3–8.
   PubMed Web of Science ®Google Scholar
• Mörner S, Hellman U, Suhr OB, Kazzam E, Waldenström A. Amyloid heart disease mimicking hypertrophic cardiomyopathy. J Intern Med 2005;258:225–230.
   PubMed Web of Science ®Google Scholar
• Olofsson BO, Andersson R, Furberg B. Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Scand 1980;208:77–80.
   PubMedGoogle Scholar
• Nowak G, Suhr OB, Wikström L, Wilczek H, Ericzon BG. The long-term impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patients. Transpl Int 2005;18:111–115.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, Gjertsen H, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): A single-center experience over 16 years. Am J Transplant 2007;7:2597–2604.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Wixner J, Obayashi K, Ando Y, Ericzon BG, Friman S, Uchino M, Suhr OB. Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients’ survival. Liver Transpl 2009;15:1229–1235.
   PubMed Web of Science ®Google Scholar
• Rapezzi C, Riva L, Quarta CC, Perugini E, Salvi F, Longhi S, Ciliberti P, et al. Gender-related risk of myocardial involvement in systemic amyloidosis. Amyloid 2008;15:40–48.
   PubMed Web of Science ®Google Scholar
• Gonçalves I, Alves CH, Quintela T, Baltazar G, Socorro S, Saraiva MJ, Abreu R, Santos CR. Transthyretin is up-regulated by sex hormones in mice liver. Mol Cell Biochem 2008;317:137–142.
   PubMed Web of Science ®Google Scholar
• Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007;14:277–282.
   PubMed Web of Science ®Google Scholar
• Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000;274:702–706.
   PubMed Web of Science ®Google Scholar
• Westermark P, Bergström J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: Clinicopathologic and structural considerations. Amyloid 2003;10:48–54.
   PubMed Web of Science ®Google Scholar
• Koike H, Ando Y, Ueda M, Kawagashira Y, Iijima M, Fujitake J, Hayashi M, et al. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 2009;287:178–184.
   PubMed Web of Science ®Google Scholar
• Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med 2011;89:171–180.
   PubMed Web of Science ®Google Scholar
• Suhr OB, Andersen O, Aronsson T, Jonasson J, Kalimo H, Lundahl C, Lundgren HE, et al. Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in Sweden. Amyloid 2009;16:208–214.
   PubMed Web of Science ®Google Scholar